• 1. Naphthalene-dioxygenase catalysed cis-dihydroxylation of bicyclic azaarenes
  Claude Chopard,Gildas Bertho,Thierry Prangé RSC Adv. 2012 2 605
• 2. Geometry-dependent divergence in the gold-catalyzed redox cascade cyclization of o-alkynylaryl ketoximes and nitrones leading to isoindoles
  Hyun-Suk Yeom,Youngun Lee,Ji-Eun Lee,Seunghoon Shin Org. Biomol. Chem. 2009 7 4744
• 3. 1,3-Dipolar character of six-membered aromatic rings. Part XVI. Reactions of benzyne with 3-hydroxypyridine, 1-methyl-3-oxidopyridinium, and related compounds
  Nicholas Dennis,Alan R. Katritzky,Stuart K. Parton J. Chem. Soc. Perkin Trans. 1 1976 2285
• 4. 652. Hydrogen transfer. Part XVI. Dihydrides of nitrogenous heterocycles as hydrogen donors
  E. A. Braude,J. Hannah,Reginald Linstead J. Chem. Soc. 1960 3249
• 5. 1002. The tautomerism of N-heteroaromatic hydroxy-compounds. Part II. Ultraviolet spectra
  S. F. Mason J. Chem. Soc. 1957 5010

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives Isoquinolines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives

Isoquinolin-4-ol (CAS No. 3336-49-0): An Overview of Its Properties, Applications, and Recent Research

Isoquinolin-4-ol (CAS No. 3336-49-0) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 4-hydroxyisoquinoline, is a derivative of isoquinoline, a heterocyclic aromatic organic compound with a wide range of biological activities. The unique structure of Isoquinolin-4-ol makes it an attractive candidate for various applications, including drug discovery and development.

The chemical structure of Isoquinolin-4-ol consists of a benzene ring fused with a pyridine ring, with a hydroxyl group attached to the fourth position of the isoquinoline ring. This arrangement confers the compound with specific chemical properties that are crucial for its biological activities. The hydroxyl group can participate in hydrogen bonding and other interactions, making Isoquinolin-4-ol a potent ligand for various biological targets.

In recent years, extensive research has been conducted to explore the potential therapeutic applications of Isoquinolin-4-ol. One of the most promising areas of research is its role as an antioxidant and anti-inflammatory agent. Studies have shown that Isoquinolin-4-ol exhibits strong antioxidant properties, which can help protect cells from oxidative stress and damage caused by reactive oxygen species (ROS). This property makes it a potential candidate for treating various diseases associated with oxidative stress, such as neurodegenerative disorders and cardiovascular diseases.

Moreover, Isoquinolin-4-ol has been found to possess anti-inflammatory effects. Inflammatory responses are often involved in the pathogenesis of many chronic diseases, including arthritis and inflammatory bowel disease (IBD). Research has demonstrated that Isoquinolin-4-ol can inhibit the production of pro-inflammatory cytokines and reduce inflammation in both in vitro and in vivo models. These findings suggest that Isoquinolin-4-ol could be developed into a novel anti-inflammatory drug.

Beyond its antioxidant and anti-inflammatory properties, Isoquinolin-4-ol has also shown promise in cancer research. Several studies have reported that Isoquinolin-4-ol can induce apoptosis (programmed cell death) in cancer cells while sparing normal cells. This selective cytotoxicity is highly desirable in cancer therapy, as it can minimize side effects associated with conventional chemotherapy. Additionally, Isoquinolin-4-ol has been found to inhibit the proliferation of cancer cells by interfering with key signaling pathways involved in cell growth and survival.

The pharmacokinetic properties of Isoquinolin-4-ol have also been investigated to assess its potential as a therapeutic agent. Studies have shown that it has good oral bioavailability and can be effectively absorbed into the bloodstream after oral administration. Furthermore, it exhibits favorable metabolic stability and low toxicity, making it suitable for long-term use in clinical settings.

In addition to its therapeutic applications, Isoquinolin-4-ol has been explored for its use in diagnostic imaging. Due to its ability to bind to specific biomarkers, it can be used as a contrast agent in imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET). This application could enhance the accuracy and sensitivity of diagnostic procedures, leading to better patient outcomes.

The synthesis of Isoquinolin-4-ol has been optimized through various methods to improve yield and purity. Common synthetic routes include Pictet-Spengler condensation followed by hydrolysis or reduction steps. These methods have been refined to ensure high efficiency and scalability, making large-scale production feasible for industrial applications.

In conclusion, Isoquinolin-4-ol (CAS No. 3336-49-0) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure confers it with diverse biological activities, including antioxidant, anti-inflammatory, and anticancer properties. Ongoing research continues to uncover new applications and mechanisms of action for this compound, highlighting its importance in the development of novel therapeutic agents. As more studies are conducted, Isoquinolin-4-ol is likely to play an increasingly important role in advancing medical treatments and improving patient care.

• 2439-04-5(5-Hydroxyisoquinoline)
• 109-00-2(3-Hydroxypyridine)
• 3482-14-2(Isoquinolin-8-ol)
• 580-18-7(quinolin-3-ol)
• 7651-82-3(6-Hydroxyisoquinoline)
• 36034-54-5(4-Methoxyisoquinoline)
• 15365-53-4(Isoquinolin-4-ol hydrochloride)
• 62215-36-5(Isoquinoline, 4-phenoxy-)
• 7651-83-4(Isoquinolin-7-ol)
• 33364-92-0(4-Hydroxyisoquinoline)